449 related articles for article (PubMed ID: 27061271)
1. Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study.
Linkins LA; Warkentin TE; Pai M; Shivakumar S; Manji RA; Wells PS; Wu C; Nazi I; Crowther MA
J Thromb Haemost; 2016 Jun; 14(6):1206-10. PubMed ID: 27061271
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban as an Alternative Agent for Heparin-Induced Thrombocytopenia.
Farasatinasab M; Zarei B; Moghtadaei M; Nasiripour S; Ansarinejad N; Zarei M
J Clin Pharmacol; 2020 Oct; 60(10):1362-1366. PubMed ID: 32519800
[TBL] [Abstract][Full Text] [Related]
3. Design of the rivaroxaban for heparin-induced thrombocytopenia study.
Linkins LA; Warkentin TE; Pai M; Shivakumar S; Manji RA; Wells PS; Crowther MA
J Thromb Thrombolysis; 2014 Nov; 38(4):485-92. PubMed ID: 24549975
[TBL] [Abstract][Full Text] [Related]
4. Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia.
Davis KA; Davis DO
Eur J Haematol; 2017 Oct; 99(4):332-335. PubMed ID: 28672052
[TBL] [Abstract][Full Text] [Related]
5. Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia.
Cirbus K; Simone P; Austin Szwak J
J Clin Pharm Ther; 2022 Jan; 47(1):112-118. PubMed ID: 34704283
[TBL] [Abstract][Full Text] [Related]
6. Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.
Warkentin TE; Pai M; Linkins LA
Blood; 2017 Aug; 130(9):1104-1113. PubMed ID: 28646118
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of heparin-induced thrombocytopenia with rivaroxaban. Case report].
Rivera O G; Corsi S O; Pavlovic J A; Aizman S A; Varas A P
Rev Med Chil; 2017 Sep; 145(9):1213-1217. PubMed ID: 29424412
[TBL] [Abstract][Full Text] [Related]
8. Rivaroxaban in treatment refractory heparin-induced thrombocytopenia.
Casan JM; Grigoriadis G; Chan N; Chunilal S
BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27520997
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban in the Treatment of Heparin-Induced Thrombocytopenia.
Sartori M; Favaretto E; Cini M; Legnani C; Cosmi B
J Thromb Thrombolysis; 2015 Oct; 40(3):392-4. PubMed ID: 25804370
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences.
Samoš M; Bolek T; Ivanková J; Stančiaková L; Kovář F; Galajda P; Kubisz P; Staško J; Mokáň M
J Cardiovasc Pharmacol; 2016 Nov; 68(5):391-394. PubMed ID: 27464495
[TBL] [Abstract][Full Text] [Related]
11. Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry.
Maeda T; Nakagawa K; Murata K; Kanaumi Y; Seguchi S; Kawamura S; Kodama M; Kawai T; Kakutani I; Ohnishi Y; Kokame K; Okazaki H; Miyata S
Thromb Haemost; 2017 Jan; 117(1):127-138. PubMed ID: 27734072
[TBL] [Abstract][Full Text] [Related]
12. The association of anti-platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery.
Welsby IJ; Krakow EF; Heit JA; Williams EC; Arepally GM; Bar-Yosef S; Kong DF; Martinelli S; Dhakal I; Liu WW; Krischer J; Ortel TL
J Thromb Haemost; 2017 Jan; 15(1):57-65. PubMed ID: 27714919
[TBL] [Abstract][Full Text] [Related]
13. The management of heparin-induced thrombocytopenia.
Keeling D; Davidson S; Watson H;
Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia.
Snodgrass MN; Shields J; Rai H
Clin Appl Thromb Hemost; 2016 Nov; 22(8):712-717. PubMed ID: 27179015
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia.
Albuloushi A; Rhoten M; Kelly J; Sylvester KW; Grandoni J; Connors JM
J Thromb Thrombolysis; 2022 Nov; 54(4):597-604. PubMed ID: 36129561
[TBL] [Abstract][Full Text] [Related]
16. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A
J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190
[TBL] [Abstract][Full Text] [Related]
17. Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol.
Ghaziri D; Dehaini H; Msheik M; Bahmad M; Zorkot M; Saad GA
BMC Pharmacol Toxicol; 2023 Jan; 24(1):2. PubMed ID: 36639796
[TBL] [Abstract][Full Text] [Related]
18. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
Lobo B; Finch C; Howard A; Minhas S
Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
[TBL] [Abstract][Full Text] [Related]
19. Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban.
Manji F; Warkentin TE; Sheppard JI; Lee A
Platelets; 2020; 31(1):124-127. PubMed ID: 31397594
[TBL] [Abstract][Full Text] [Related]
20. Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia.
Joseph L; Casanegra AI; Dhariwal M; Smith MA; Raju MG; Militello MA; Gomes MP; Gornik HL; Bartholomew JR
J Thromb Haemost; 2014 Jul; 12(7):1044-53. PubMed ID: 24766902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
